Bladder Cancer
Predicting bladder cancer risk in patients with hematuria. A single-centre retrospective study.
March 24, 2023
Anthropometric characteristics and relationship with non-muscle invasive bladder cancer in Greece: A case-control study.
March 23, 2023
Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade.
March 23, 2023
Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer.
March 22, 2023
Examining the Role of Microbiota-Centered Interventions in Cancer Therapeutics: Applications for Urothelial Carcinoma.
March 22, 2023
National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy.
March 21, 2023
Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer.
March 20, 2023
Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy.
March 20, 2023
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.
March 17, 2023
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
March 17, 2023
Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.
March 16, 2023
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.
March 15, 2023